Created by Doctors for Doctors

RDL is proud to have been chosen by the Systemic Lupus International Collaborating Clinics (SLICC) to perform the Autoimmune serologic testing for the 2012 SLICC Classification Criteria.

Serum Repository

To search for available samples in RDL’s Serum Repository, click here.

14-3-3η Biomarker

14-3-3η Biomarker: Serial decrease/clearance predicts better radiographic outcomes in Rheumatoid Arthritis (RA) Read More…

RAdx3 (including 14-3-3): Increases sensitivity for early or seronegative Rheumatoid Arthritis Read More…

Anti-SAE-1 Autoantibody

Anti-SAE-1 Autoantibody: Highly specific (>95%) for Dermatomyositis (DM). Helps differentiate from other forms of Idiopathic Inflammatory Myopathies (IIM) Read More…

Part of MyoMarker™ Panel 3 Plus Read More…

Anti-IBM Antibody (Anti-cN-1A)

Anti-cN-1A autoantibodies in idiopathic inflammatory myopathy (IIM) patients appear to be disease-specific for sIBM and are rarely detected in other autoimmune conditions. Read More…

Anti-HMGCR Autoantibodies

HMGCR Abs (3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase) are associated with necrotizing myopathy that is commonly related to statin exposure. Read More…

RDL’s MyoMarker™ Panels

Myositis autoantibodies have been shown to be highly specific for patients with Polymyositis, Dermatomyositis and overlap syndromes. Read More…

RDL Presents – Yehuda Shoenfeld, M.D. (FRCP)

Video presentations